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Diabetic cardiomyopathyEndoplasmic reticulum (ER) stress, together with the unfolded protein response (UPR), is initially considered an
adaptive response aiming atmaintenance of ER homeostasis. Nonetheless, ER stress, when in excess, can eventu-
ally trigger cell apoptosis and loss of function. UPR ismediated by threemajor transmembrane proteins, including
inositol-requiring enzyme 1 (IRE1), protein kinase RNA-like ER kinase (PERK), and activating transcription factor
(ATF) 6. A unique role has been speculated for ER stress in the pathogenesis of diabetes mellitus (DM) and its
complications. Recent studies have shown that ER stress is an early event associated with diabetic cardiomyop-
athy, and may be triggered by hyperglycemia, free fatty acids (FFAs) and inﬂammation. In this mini-review, we
attempted to discuss the activationmachinery for ER stress in response to these triggers en route to disrupted ER
function and cellular autophagy or apoptosis, ultimately insulin resistance and development of diabetic cardio-
myopathy. This article is part of a Special Issue entitled: Autophagy and protein quality control in cardiometabolic
diseases.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Diabetes mellitus (DM) is a chronic, progressive metabolic disorder
characterized by deﬁciency of insulin secretion, loss of insulin sensitivi-
ty or both, resulting in elevated plasma glucose levels. Individuals with
DM display an increased risk for macro- and micro-vascular complica-
tions [1,2]. These vascular injuries often coexist and contribute to the
onset and progression of hypertension, ischemia as well as diastolic/
systolic dysfunction [3]. Moreover, cardiovascular complications ac-
count for the high morbidity and mortality in diabetic populations.
When compared to the age-matched controls, the relative risk of heart
failure is 2-fold greater in diabetic males, and 5-fold greater in diabetic
females, independent of age, ethnicity, body mass, dyslipidemia and
coronary artery disease according to the Framingham Heart Study [4].
Diabetic cardiomyopathy is a distinct myocardial disease in patients
with DM, leading to the structural and functional changes in the heart
independently of hypertension, coronary artery and valvular heart dis-
ease [5]. These changes can eventually result in left ventricular hyper-
trophy (LVH) and diastolic/systolic dysfunctions [6]. An array ofy and protein quality control in
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level, contributing to the etiology of diabetic cardiomyopathy such as
perturbations of intracellular energymetabolism, alterations in intracel-
lular ion homeostasis and oxidative stress [7–9]. More recently, ER
stress was suggested to contribute to the onset and progression of dia-
betic cardiomyopathy [10,11]. Nevertheless, the precise interplay
among ER stress, development of cardiac hypertrophy and progression
to heart failure still remains elusive.
ER is an organelle with rough and smooth regions. The rough region
of membrane forms stacks of ﬂattened cisternae and is composed of a
membrane-enclosed lumen. The smooth region of membrane is con-
nected to these membranous cisternae to form a ﬁne network of tu-
bules. Polypeptide chains of secreted, transmembrane and luminal
proteins synthesize, fold andmature in the ER lumen [12]. It also serves
as a site for lipid biosynthesis and Ca2+ storage [13]. Nascent polypep-
tides are transferred into the ER lumen, undergoing posttranslational
modiﬁcations and rounds of folding interactions in order to optimize
their functions. Correctly folded proteins then move away from the ER
to remote intracellular organelles and the extracellular surface, while
misfolded proteins are either retainedwithin the ER or subject to degra-
dation by cytoplasmic proteasomes [14].
Efﬁcient ER function relies heavily on numerous quality control fac-
tors, such as molecular chaperones, folding enzymes and a Ca2+-rich
environment [15]. When ER homeostasis is aberrant under the condi-
tions of radiation, hypoxia, ischemia, oxidation or dysregulation of
Ca2+, ER stress response will be triggered to cope with this imbalance,
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in 1988 as an adaptivemechanism to increase the protein folding capac-
ity aswell as to decrease the unfolded protein load [16]. TheUPR aims to
restore the ER homeostasis by (1) decreasing the load of proteins in the
ER via translational attenuation, (2) increasing the transcription of
chaperones and other proteins involved in the folding and maturation
of proteins, and (3) inducing the degradation of misfolded proteins via
the ER-associated degradation (ERAD) complex [17]. If it fails, ER initi-
ates the death signaling pathways [18].
In this mini-review, we will attempt to discuss the possible mecha-
nisms behind the potential contribution of ER stress and UPR in the
pathogenesis of diabetic cardiomyopathy, in an effort to provide some
evidence for the potential UPR-targeted therapies for this disease.2. Protein quality control and signaling pathways of the UPR
Quality control is a complicated mechanism that maintains the pro-
tein biosynthesis with properly folded and assembled structures in the
ER [19]. It relies on molecular chaperones and folding enzymes to mon-
itor and assist the folding process. These chaperones and enzymes can
be classiﬁed into threemajor groups: (1) binding protein/glucose regu-
lated protein (BiP/GRP) 78, GRP94, (2) calnexin (CNX) and calreticulin
(CRT), (3) protein disulﬁde isomerase, such as ER protein (ERp) 57
and ERp72 [15]. GRP78 andGRP94have the ability to recognize exposed
hydrophobic regions, a common feature of nascent misfolded proteins,
thus assisting protein folding and assembling [20]. CNXand CRT interact
with glycoproteins via their lectin binding ability, allowing folding and
interacting with enzymes [21,22]. ERp57 uses the oxidative environ-
ment of the ER to generate disulﬁde linkages, which are directly affected
by the primary donor of the energy [23]. If quality control is unable to
fold the protein, the UPRwill be triggered by the continuous accumulat-
ed unfolded/misfolded proteins in three transmembrane protein-
mediated signaling pathways, namely inositol-requiring enzyme 1
(IRE1), protein kinase RNA-like ER kinase(PERK) and activating tran-
scription factor (ATF) 6 pathways (Fig. 1) [24]. Under physiologicalFig. 1.When ER is unable to fold secretory and membrane proteins, the accumulated unfolded
pathways, as IRE1, PERK and ATF6 pathways.conditions, these sensors are maintained in an inactive state by binding
to GRP78, while ER stress increases the binding of BiP to the luminal
misfolded proteins, and the resultant sequestration away from IRE1,
PERK and ATF6 usually leads to the activation of these ER stress signal-
ing molecules [25].
2.1. IRE1 signaling pathway
IRE1 is consist of an N-terminal luminal sensor domain, a single
transmembrane domain and a C-terminal cytosolic effect or region
which manifests both kinase and endoribonuclease activity [26]. There
are two isoforms of IRE1 namely IRE1α and -1β. The UPR is mainly
governed by IRE1α. Upon activation, IRE1αmediates an unconvention-
al cytoplasmic splicing, to remove a 26-nucleotide intron from X-box-
binding protein 1 (XBP1) mRNA, yielding a fusion protein XBP1s [27].
XBP1s act as a potent transcription factor for the expression of potential
UPR target genes, to upregulate the ER chaperones, components of the
ERAD complex and the biosynthesis of phospholipid, and to export
and degrade misfolded proteins in an effort to resolve ER stress [28].
IRE1 activates Jun N terminal kinase (JNK) by recruiting the apoptosis
signal-regulating kinase 1 (ASK1), caspase-12 and tumor necrosis factor
receptor-associated factor 2 (TRAF2), which are pro-apoptotic [29].
Many cell metabolismmodulators regulate the IRE1 pathway. IRE1α
is phosphorylated by PKA, to control the glucagon-mediated expression
of gluconeogenic genes [30]. Both XBP1 splicing and JNK activation are
controlled by the mammalian target of rapamycin complex 1
(mTORC1), the major sensor of nutrient and energy in cells [31,32].
P85, a repressive regulatory subunit of PI3K, also interacts with XBP1,
increasing its nuclear translocation and transcriptional activity [33].
2.2. PERK signaling pathway
PERK is a type 1 transmembrane protein that possesses a luminal do-
main similar to that of IRE1, and a cytoplasmic portion that possesses
protein serine/threonine kinase activity. It has a PEK-like catalytic/misfolded proteins trigger the UPR in three transmembrane protein-mediated signaling
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tor 2α (eIF2α) [34]. P58IPK, one of the heat shock protein 40 (HSP40)
family members, regulates PERK by binding to the kinase domain of
the sensor and decreasing eIF2α phosphorylation [35]. This regulation
affects the expression of its downstream targets, reducing the transla-
tion of the UPR target proteins BiP and C/EBP homologous protein
(CHOP) [36].
When activated, PERK phosphorylatesα-subunit of eIF2α on serine-
51, down regulating cap- or eIF2α-dependent translation, thus shutting
off global mRNA translation [37]. The inhibition of global translation re-
duces the protein-folding load on the ER and allows the cell to focus re-
sources on resolving the ER stress, thus facilitating survival. In contrast
to inhibition of general mRNA translation, the PERK/eIF2α pathway
stimulates the translation of several speciﬁcmRNAs containingmultiple
53-upstream open reading frames, such as ATF4, CHOP and growth ar-
rest and DNAdamage (GADD) 34 [38]. PERK also phosphorylates nucle-
ar factor (erythroid-derived 2)-related factor2 (Nrf2), resulting in its
translocation to the nucleus where it turns on expression of oxidative
genes in response to oxidative stress [39]. Therefore, this signaling path-
way of the UPR acts to preserve redox balance during ER stress through
activation of ATF4 and Nrf2. In addition to its role in ER stress, PERK also
takes part in the activation of autophagy as a survivalmechanismduring
episodes of nutrient deprivation, hypoxia and radiation [40,41].2.3. ATF6 signaling pathway
ATF6, also known as basic leucine zipper protein (bZIP), is an ER-
associated type 2 transmembrane protein with three structural do-
mains: a luminal C-terminal, a transmembrane and a cytoplasmic N-
terminal domain. Two isoforms have been described: ATF6α and
ATF6β. In the luminal domain, ATF6 has Golgi localization sequences
(GLS), two in the ATF6α isoform (GLS1 and GLS2) and one (GLS2) in
the ATF6β isoform [42]. Under basal conditions, ATF6 is retained in
the ER via interactionwith the chaperone BiP/GRP78 and CRT [43]. Dur-
ing the ER stress, ATF6α and ATF6β are released from BiP prior to trans-
location to the Golgi complex [44], where they are cleaved by Golgi-
resident proteases, ﬁrst by site 1 protease (S1P) and then in the
intramembrane region by S2P [45]. These intra-membrane proteases
were initially implicated in the cleavage of the transcription factor ste-
roid regulatory element-binding protein (SREBP), involved in lipid me-
tabolism. The cleaved-off cytoplasmic domain is a transcriptionalFig. 2. ER stress gets activated in numerous organs of metabolic syndrome, including the hactivator of genes involved in ERAD, lipid biosynthesis, protein folding
and ER expansion [46].
A series of ATF6 homologues have been identiﬁed that undergo sim-
ilar processing at the Golgi and possess tissue-speciﬁc roles, including
cAMP responsive element-binding protein (CREB) H, CREB3 (Luman),
CREB3L1 (Oasis), CREB3L2 (BBF2H7) and CREB4 (Tisp40) [12]. CREB3
is expressed in monocytes and dendritic cells and CREB3L1 is highly
expressed in astrocytes and osteoblasts. Although it is reported to par-
ticipate in the expression of numerous genes involved in the ERAD,
the pathophysiological triggers and mechanisms behind activation of
such sensor remain somewhat elusive [47].
3. ER stress in the complications of DM
3.1. ER stress in metabolic disorder
ER stress can be activated in response to metabolic syndrome in
multiple organs, including the hypothalamus, liver, adipose tissue,
muscle and pancreatic β cells (Fig. 2) [48]. The hypothalamus regulates
caloric intake and energy expenditure in response to signals delivered
by leptin, insulin, nutrients and gut hormones [49], whereas hypotha-
lamic ER stress leads to inﬂammation and leptin/insulin resistance.
M. Milanski and colleagues demonstrated that hypothalamic ER stress
occurred upon the activation of toll-like receptor (TLR) 4 signaling, the
effect of which could be reversed by genetic or pharmacological disrup-
tion of TLR4 by both in vivo (rats) and in vitro (isolated hypothalamic
tissues) studies [50]. This ﬁnding received convincing support from
other studies as well [51,52]. Chronic hepatic ER stress is wildly con-
ceived to promote the onset and development of insulin resistance in
obese animals and humans [53–55]. ER stress in adipose tissues inhibits
insulin signaling, represses lipolysis, and alters secretion of adipokines,
such as insulin receptor substrate (IRS) 1 and IRS2 [56]. In a recent clin-
ical study comparing various fat depots, BiP and XBP1 were highly
expressed in visceral compared with subcutaneous fat, and more pro-
nounced in severe obesity [57]. Liu and coworkers showed that de-
creased ER disulﬁde-bond A oxidoreductase-like (DsbA-L) protein
expression compromised adiponectin folding and multimerization,
leading to ER stress in obesity [58,59]. ER stress also inhibits resistin
transcription in murine adipocytes through upregulation of CHOP [60].
Saturated fats cause ER stress in muscles while prolonged ER stress im-
pairs insulin synthesis and triggers apoptosis in pancreatic β cells
[61–64].ypothalamus, liver, adipose tissue, muscle and pancreatic β cells as well as the heart.
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Diabetes mellitus is usually accompanied with cardiac hypertrophy,
inﬂammation, interstitial ﬁbrosis, aberrant intracellular Ca2+ handling,
endothelial dysfunction and defective substrate metabolism. Disturbed
cardiomyocyte hemostasis may facilitate ER stress and the UPR to par-
ticipate in the onset and progression of cardiomyocyte hypertrophy
and heart failure bymodulating ATP, ER Ca2+, andUDP-glucose. Quality
control changes its molecular chaperones in order to reverse the onset
and progression of diabetic cardiomyopathy. First of all, in vivo evidence
depicted an increase in the synthesis of BiP/GRP78, accompanied with
the activation of the XBP1, IRE1α/TRAF2 signal cascades in pressure
overload elicited hypertrophy [65,66]. Mao and coworkers demonstrat-
ed that autoimmune cardiomyopathy induced by β1-adrenergic recep-
tor peptide was associated with an increase of ATF6 cleavage as well
as nuclear translocation, which might then lead to ER stress [67].
CHOP knockoutmice displayed a less pronounced hypertrophy and car-
diac dysfunction in comparison with wild type animals [68]. Transgenic
mice expressing a mutant of KDEL receptor or expressing a dominant
negative mutant of ATF6 showed dilated cardiomyopathy, enhanced
expression of CHOP and compromised cardiac function [69,70]. Further-
more, clinical trial observed that human sarco/ER Ca2+ATPase (SERCA)
3f up-regulated in failing hearts frompatientswith diverse cardiomyop-
athies and the overexpression of SERCA3f paralleled an increase in ER
stress markers, such as processing of XBP1 and GRP78 [71]. All these
studies suggest that ER stress is induced in the diabetic heart and
the UPR-associated metabolic disturbances altered Ca2+ handling,Fig. 3. Diabetes causes high plasma glucose level, elevating the amount of FFAs, activating the
stress, disrupt ER function and cause cell autophagy or apoptosis as well as insulin resistance,oxidative stress and apoptosis participate in the pathogenesis of diabet-
ic cardiomyopathy [72].
4. Triggers of ER stress in the diabetic cardiomyopathy
Pathological cardiac hypertrophy in diabetic cardiomyopathy is ac-
companied with alterations in both intracellular Ca2+ homeostasis
and metabolism, which, together with increased protein synthesis, can
induce ER stress and consequently trigger the UPR. Three likely major
triggers have been postulated to induce ER stress including hyperglyce-
mia, FFAs and inﬂammation (Fig. 3).
4.1. Hyperglycemia
Hyperglycemia represents one of the principal drivers for metabolic,
functional and structural alterations present in diabetic hearts. Aberra-
tions in glucose control cause a series of changes in the microenviron-
ment of cardiomyocyte, including deletion of glucose transporter 4
(GLUT4), generation of reactive oxygen species (ROS), alteration of
Ca2+ level and hyperinsulinemia and insulin resistance. All these chang-
es alter the homeostasis of ER, which ﬁnally trigger UPR. As hyperglyce-
mia becomes chronic in diabetes, glucose that normally serves as fuel or
substrate is used to generate detrimental metabolites for cardiomyo-
cyte. Lakshmanan and colleagues proved that hyperglycemia-
stimulated myocardial ER stress contributes to diabetic cardiomyopa-
thy. After further study, they showed that PERK and ATF6 pathways
were activated, whereas IRE1α-XBP1 pathway was not activated ininﬂammation and altering cardiac metabolism and lipotoxicity as well, which trigger ER
thus ﬁnally leading to diabetic cardiomyopathy.
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signiﬁcantly up-regulated expression of the sub-arm of UPR signaling
proteins, such as p-PERK, p-eIF2α, ATF6, CHOP/GADD153, TRAF2 [73].
UPR was found to be intact in high fat diet (HFD) fed rats as evidenced
by increased PERK phosphorylation and GRP78 levels in relation to the
primary ER client proteins insulin and islet amyloid polypeptide
(IAPP) [74]. Moreover, alleviated ER stress is noted when hyperglyce-
mia and glucose intolerance are improved [75].
4.2. FFAs
FFAs are the primary energy substrate used by the heart and are sup-
plied to cardiac cells via serum, lipoproteins or lipolysis of triglycerides
in the heart. The abnormal state of energy metabolism in the diabetic
heart leads to an increased amount of fatty acid extraction and storage.
Indeed, hearts from diabetic and/or obese animals show an over reli-
ance on FFAs for energy production and have accelerated rates of fatty
acid oxidation [76].
High level of FFAs in the circulation and cells may trigger a series
of unfavorable stress responses in cardiomyocyte including ER stress.
Li and colleagues reported that accumulation of saturated FFA-
containing phospholipids inhibits SERCA2b activity because of a loss in
membrane ﬂuidity caused by increased ordering of the ER membrane
[77], thereby causing Ca2+ depletion and protein misfolding. Boslem
also showed that FFAs induced the depletion of ER Ca2+ and impeded
protein trafﬁcking by ceramide synthesis [78]. Pulinilkunnil and col-
leagues demonstrated that FFAs induced cardiomyocyte apoptosis in
type 1 diabetic Akita mice through upregulation of CHOP and activation
of JNK. With cardiac-speciﬁc overexpression of the adipose triglyceride
lipase in mice, expression of cardiac ER stress biomarkers of GRP94,
CHOP, CRT, CNX, phosphorylated PERK Thr980, p38 mitogen activated
protein kinases (MAPK) phosphorylation, and p38MAPK was reduced
[79]. Prolonged type 2 DM can activate UPR in response to hyperglyce-
mia although FFAs may trigger cardiac ER stress early on lipotoxic
cardiomyopathy.
4.3. Inﬂammation
In the progress of diabetic cardiomyopathy, macrophages, neutro-
phils, mast cells, blood platelets and T cells are quickly activated in re-
sponse to cardiovascular insults, a process commonly regarded as the
inﬂammatory reaction [80]. For example, the presence of damaged
cells and cell debris can induce activation of resident macrophages,
leading to the release of pro-inﬂammatory cytokines and other mole-
cules, like ROS and proteases, which cause damaging or protective ef-
fects on endothelial cells, smooth muscle cells and cardiomyocyte as
well [81]. The inﬂammatory reaction is generally triggered by the acti-
vation of pattern recognition receptors, such as TLRs [50]. Fas ligands re-
leased by dying inﬁltrating inﬂammatory cells can initiate an intense
inﬂammatory response, contributing to the onset and development of
cardiomyopathy as well as heart failure [82,83].
Chronic infection and subsequent production of cytokines may lead
to a several-fold ampliﬁcation of inﬂammatory response in endothelial
cells and cardiomyocyte, with increased ER stress and cell apoptosis
[84,85]. It has been indicated that activation of TLR-signal can activate
IRE1 with a permissive role for its downstream target XBP1 in the pro-
duction of pro-inﬂammatory cytokines such as TNF-α, monocyte
chemoattractant protein (MCP) 1 and interleukin (IL) -6, IL-8 in macro-
phages and endothelial cells, resulting in augmented TLR responses con-
tributing to inﬂammation [86]. MCP-1 is an angiogenic factor associated
with the recruitment of monocytic cells. Cardiac-speciﬁc expression of
MCP-1 in mice causes inﬂammation and cell apoptosis [87]. Studies
showed that ER stress response pathways, the UPR and ERAD, were
highly activated in the hearts of MCP mice during the development of
cardiovascular disease [88,89]. Different pro-inﬂammatory cytokines
seem to preferentially affect different branches of the UPR, such as IL-1β induces Xbp1 splicing and PERK/eIF2α phosphorylation [90], while
IFN-γ decreases expression of Xbp1s, Bip and several other ER chaper-
ones downstream of ATF6/XBP1s, sensitizing cardiomyocyte to apopto-
sis induced by chemical ER stressors or IL-1 receptor [72].
Intra-myocardial contents of cytokines may disrupt the oxidative
state of ER, resulting in the impairment of ER function and UPR. The ox-
idative state of the heart inﬂuences several proteins to disrupt energy
utilization in the ER and activate the PERK/CHOP pathway, leading to
the UPR [91]. These ﬁndings denote an important role for inﬂammation
in the onset and progression of diabetic cardiomyopathy.
5. Role of ER stress in diabetic cardiomyopathy
ER stress responses, ER Ca2+ buffering, as well as protein and lipid
turnover impact many cardiac functions, including energy metabolism,
cardiogenesis, cardiac insulin resistance and heart failure.
5.1. Autophagy
Autophagy is a highly conserved cellular process for degradation and
recycling of membranes, organelles, and cytoplasmic components in ly-
sosomes. This process has been widely identiﬁed as an essential myo-
cardial adaptive response to maintain energy homeostasis at both
basal and stress conditions through a number of autophagy genes
(Atgs) [92]. A plethora of stress conditions, including nutrient and ener-
gy starvation, oxidative stress, metabolic dysfunction and ER stress are
observed to activate autophagy as a pro-survival pathway [93]. ER stress
can induce autophagy in several canonical UPR pathways (Fig. 4). Ca2+
releases from the ER can stimulate different kinases that regulate au-
tophagy. Ca2+/calmodulin-dependent kinase kinase β (CaCMKKβ)
phosphorylates and activates AMPK, leading to mTORC1 inhibition
[94]. mTORC1 has been proposed to regulate autophagy by repressing
the Atg1–Atg13–Atg101/FIP200 complex, thus inhibition ofmTORC1 fa-
cilitates the initiation of autophagy [95–97]. The IRE1 arm of ER stress
leads to JNK activation and increased phosphorylation of B cell
lymphoma-2 (Bcl-2), which promotes its dissociation from Beclin-1
[98,99]. In addition, PERK-eIF2α-ATF4-dependent Atg12 upregulation
is required for induction of autophagy in response to polyQ protein ac-
cumulation [100]. Recently, researchers suggest that ER stress may be
both a trigger and consequence for autophagy. ER stress can induce au-
tophagy in the UPR pathwaymentioned above, while impaired autoph-
agy may also contribute to ER stress. It has been suggested that
restoration of autophagy alleviates obesity-induced ER stress [87,100].
In diabetic heart, ER stress may induce autophagy. Younce and col-
leagues demonstrated that hyperglycemia promotedMCP-1 production
and MCP-1-induced protein (MCPIP) induction, leading to oxidative
stress and activation of UPR. The MCPIP-induced UPR activation could
upregulate IRE1, resulting in JNK activation and eventually autophagy.
Prolonged autophagy ﬁnally led to cardiomyocyte apoptosis [87]. Our
studies suggested that lessened phosphorylation of Akt-tuberous scle-
rosis complex (TSC), en route to dampened mTOR phosphorylation
and then excess autophagy following thapsigargin challenge. These
data indicate a role for Akt-mTOR-mediated autophagy in ER stress-
induced cardiac anomalies [101]. The resultant cardiomyocyte contrac-
tile dysfunction can be reversed by heavy metal scavenger metallothio-
nein. It signiﬁcantly attenuated or ablated tunicamycin (TM)-induced
elevation of autophagy markers or regulatory signals including phos-
phorylated serine/threonine-protein kinase (ULK1), Atg5, Atg7, light
chain 3 (LC3) B-II, LC3B-II/LC3B-I ratio and p62 [102]. More recent ﬁnd-
ings have provided compelling evidence that mTOR kinase is an impor-
tant regulator of myocardial autophagy and may serve as a converging
point for the interplay between ER stress and autophagy [103].
mTORC1may be operated both up- and down-streamof ER stress, to ei-
ther enhance or suppress the anabolic output of mTORC1. However, in
depth research is needed to clarify the precise interplay between ER
stress and autophagy in the face of diabetic cardiomyopathy.
Fig. 4. ER stress can directly activate autophagy severely via threemajor signaling pathways, including (1) Ca2+-dependent pathway, (2) the IRE1/JNK pathway and (3) PERK/eIF2α/ATF4-
dependent pathway in the pathophysiological progress of many cardiovascular diseases. However, only the IRE1/JNK pathway has been demonstrated to take part in the induction of au-
tophagy by the UPR in the diabetic heart. We still lack information about the relationship between autophagy and ER stress in the onset and progression of diabetic cardiomyopathy.
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In the pathogenesis of diabetic cardiomyopathy, ER stress develops
in response to nascent protein misfolding in the ER lumen. A complex
cellular response that occurs initially acts to promote the ER recovery,
but, if the heart continues to be stressed, the UPR triggers apoptosis as
the last measure to deal with the problem. This may ultimately result
in heart failure and death. ER stress can directly induce cell apoptosis
through two signaling pathways: the IREα/JNK pathway and the
PERK/CHOP pathway. IRE1α modulates p38MAPK and extracellular
regulated protein kinases (ERK) by binding to TRAF2, and this complex
promotes apoptosis through JNK phosphorylation [104]. A dominant-
negative form of XBP1 inhibits the XBP1-dependent arm of the UPR,
leading to an increase in cardiomyocyte apoptosis during hypoxia
[105]. Furthermore, several pro-apoptotic or anti-apoptotic proteins in-
teract with IRE1α, regulating its activation state [106]. It was demon-
strated that ASk1-null primary neurons were resistant to ER stress-
induced cell apoptosis [107]. Activated ASK1 leads to JNK-mediated
phosphorylation and activation of the pro-apoptotic protein binding to
microtubule (Bim) [108], but inhibits Bcl-2 [109]. Our study proved
that TM-induced myocardial ER stress, as evidenced by upregulation
of BiP, CHOP, phosphorylated eIF2α/eIF2α, phosphorylated IRE1α/
IRE1α, signiﬁcantly increased the level of Bcl-2-associated X protein
(Bax) and Bcl-2/Bax ratio with unchanged level of Bcl-2, while
cardiac-speciﬁc overexpression of metallothionein can alleviate the
myocardial contractile dysfunction and intracellular Ca2+ mishandling
[101]. Thus, the formation of a macromolecular signaling complex of
IRE1α with several pro-apoptotic proteins can generate apoptotic sig-
nals and establish an apoptotic environment.
During the pro-survival phase of ER stress, ATF4 induces numerous
genes involved in resolution of the ER stress, such as genes that encode
amino acid transporters and ER resident chaperones. However,
sustained activation of the PERK pathway contributes to stress-induced cell apoptosis by ATF4-mediated induction of pro-apoptotic
genes, including CHOP, ATF3, and GADD34. The induced transcription
factor CHOP contributes to increased expression of the pro-apoptotic
factors, such as death receptor 5 (DR5) [110], tribbles-related protein
3 (Trb3) [111], and Bim [112], and it can suppress Bcl-2 expression.
The deletion of CHOP gene attenuates ER stress-induced apoptosis in
cultured ﬁbroblasts and partially protects mice from renal toxicity
owing to pharmacological induction of ER stress by TM. A reduction in
CHOP by knockout leads to an increase in cell survival and an alleviated
oxidase stress [113]. Bim is also activated through protein phosphatase
2A-mediated dephosphorylation, which prevents its ubiquitination and
proteasomal degradation [114]. However, ER stress is sustained due to
the diabetic lesions and the abundance of Bip, PERK, CHOP, caspase-
12, and JNK is signiﬁcantly upregulated that results in the apoptosis of
myocardial cells.
ER stress also induces the aberration of Ca2+ homeostasis, indirectly
causing cardiomyocyte apoptosis. Heart failure is characterized by a de-
cline in the force of contraction and dysregulation in intracellular Ca2+
homeostasis in myocyte [115]. Abnormal Ca2+ metabolism has been
identiﬁed in both experimental diabetic models and diabetic patients.
It involves a defect in one or more mechanisms that regulate intracellu-
lar Ca2+ concentration, including the sarcolemmal L-type Ca2+ channel,
the sarcoplasmic reticulum (SR) Ca2+ release channel, the SERCA2a, the
SERCA2a regulator phospholamban and the sarcolemmal Na+/Ca2+ ex-
changer. Impaired calcium-handling proteins such as dissociation or
downregulation of SERCA2a are linked to cardiac insufﬁciency in the di-
abetic heart [116]. It was reported that calcium-sensing receptor in-
duced ER stress via the SR and mitochondrial death pathway which
ﬁnally lead to cardiomyocyte apoptosis in the cardiac hypertrophy and
heart failure [117]. Younce and colleagues proved that exendin-4
treatment reduced ER stress with the decreased expression of
GRP78 and CHOP, leading to the enhancement of SERCA2a activity,
then attenuated cardiomyocyte apoptosis [118]. To summarize,
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diomyocyte apoptosis during the pathophysiological progress of dia-
betic cardiomyopathy.
5.3. Insulin resistance
Insulin resistance is a major characteristic of obesity and type 2 DM
and develops in multiple metabolic organs, including diabetic heart. Al-
though lipid is utilized as the primary energy source in the heart, glu-
cose becomes a critical energy source in the oxygen deﬁcient state. In
the diabetic heart, diminished activation of GLUT4 results in reduced
glucose utilization and impaired insulin signaling, which may contrib-
ute to cardiomyocyte apoptosis and abnormal cardiac functions. Many
potential drivers of cardiac insulin resistance have been found, includ-
ing mitochondrial dysfunction, inﬂammation, cytokine upregulation
and stress kinases signaling [119]. Recently, ER stress has emerged as
a new player in this ﬁeld and a considerable number of studies have
pointed out its role in the onset of insulin resistance [120].
The UPR signaling pathways thatmediate insulin action depend on a
tyrosine-phosphorylation cascade, which begins with autophosphoryl-
ation of the insulin receptor tyrosine kinase, followed by tyrosine phos-
phorylation of proximal targets such as the IRS1 [121]. Earlier evidence
revealed that Grp78-deﬁcientmiceweremore responsive to insulin sig-
naling following HFD feeding [122] with JNK1 being identiﬁed as an es-
sential member of the growing network of serine kinases that inhibited
insulin signaling [123]. Özcan and colleagues later discovered that ER
stress induced the activation of this kinase through the transcription
factor IRE1, or its downstreamsensor XBP1 [75]. Further studies demon-
strated that IRE1 activated JNK by recruiting TRAF2 and ASK1, and XBP1
activated the transcription of inﬂammatory genes that also directly con-
tributed to the insulin resistance [104,124]. Dong and colleagues re-
vealed that phosphorylated ER stress makers PERK (Thr980), IRE1,
and eIF2α were signiﬁcantly elevated in db/db mice and adiponectin,
one of the adipocytokines with cardioprotection functions, can improve
cardiomyocyte dysfunction in db/db mice through a mechanism possi-
bly related to JNK and IRS1 [125]. Several studies have addressed the
role of ER stress tomediate palmitate-induced insulin resistance inmus-
cle cells. These ﬁndings conformed that TM-induced ER stress in C2C12
or L6 muscle cells led to a decrease in insulin signaling through phos-
phorylation of IRS1 by the IRE1/JNK pathway [126,127]. Recently,
Hwang and colleagues demonstrated an important role for mTORC1-
S6 kinase 1 (S6K1) pathway and showed that TM-induced ER stress
could be prevented by pretreating cells with rapamycin, an mTORC1 in-
hibitor. Also, in S6K1 knockdown cells, TM induces ER stress through the
S6K1-dependentmechanism inmuscle [128].Moreover, treatmentwith
chemical chaperones such as 4-phenyl butyric acid or tauroursode-
oxycholic acid has been shown to attenuate ER stress and to improve in-
sulin sensitivity in diet-induced obese mice [129]. When insulin signal-
ing is impaired during chronic hyperinsulinemia, the insulin growth
factor (IGF)/Akt-induced cardiomyocyte hypertrophy may lead to a po-
tential mismatch between cardiomyocyte size and vascularity contrib-
uting to relative hypoperfusion and increased stiffness in the phase of
diastolic dysfunction. Indeed, the diabetic heart faces numerous stresses
from hyperglycemia, hyperlipidemia and hyperinsulinemia, where
insulin resistance may be a major intracellular event that predisposes
the diabetic heart for its ultimate fate.
6. Clinical therapeutic perspectives
Maneuver to alleviate ER stress for the therapy against diabetic
cardiomyopathy has drawn some attention despite many still remain
at an early stage. First of all, usingmanipulations that up-regulate a pro-
tective UPR has been proven to possess the beneﬁt for prolonged or se-
vere ER stress in diabetic heart. As standard therapeutic modalities
aiming at alleviatingmyocardial contractile dysfunction display various
disadvantages in diabetic cardiomyopathy and its complications, UPRpreconditioning, including activation of components of the adaptive
pathway of UPR to deal with the stress or inhibition of the pro-
apoptotic components of UPR, has demonstrated some promises for di-
abetic cardiomyopathy [68]. Secondly, certain low-molecular-weight
chemical chaperones may possess therapeutic potentials for diabetic
cardiomyopathy. Force and colleagues reported that proteasome inhib-
itors resulted in the accumulation of unfolded proteins to turn on UPR.
Chemical ER chaperones such as 4-phenyl butyric acidmay promote en-
dogenous ER chaperone function in the heart and serve as ideal candi-
dates to combat cardiotoxicity and harmful UPR response elicited by
proteasome inhibitors [75]. Certain newly reported cardioprotective
molecules, such as heavy metal scavenger metallothionein and mito-
chondrial aldehyde dehydrogenase (ALDH2), may also alleviate myo-
cardial contractile anomalies induced by ER stress. These molecules
may be developed as novel pro-survival therapeutic agents with clinical
utility [101].
7. Conclusion
Given the important role of ER stress in the onset and progression of
diabetic cardiomyopathy, it is imperative to understand the underlying
mechanism throughwhich ER stress evolves and affects diabetic hearts.
Although a role for ER stress in the heart has received intensive atten-
tion over the recent years from both experimental and clinical perspec-
tives, many questions remain unanswered: (1) The source(s) of ER
stress in diabetic heart and whether they display cross-talk among
them? (2) To what extent the adaptive and pro-apoptotic pathways of
the UPR may be involved in the pathophysiology of diabetic cardiomy-
opathy? (3) Can ER stress be controlled in the context of diabetic myop-
athies? and (4) Should ER stress be considered a potential target for
new drug discovery? Further studies are warranted to manipulate
in vivo ER stress activation rather than supra-physiological activation
of ER stress using chemical inducers. Given that chemical ER chaperones
are capable of modulating ER stress, small molecules should hold the
promises for future drug development to target on ER stress in diseases.
Thus, identifying novel therapeutic targets to alleviate ER stress and re-
store ER homeostasis in the heart may be an essential step toward the
management of diabetic cardiomyopathy.
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